PMID- 30147392
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240329
IS  - 1179-8467 (Print)
IS  - 1179-8467 (Electronic)
IS  - 1179-8467 (Linking)
VI  - 9
DP  - 2018
TI  - A review of contingency management for the treatment of substance-use disorders: 
      adaptation for underserved populations, use of experimental technologies, and 
      personalized optimization strategies.
PG  - 43-57
LID - 10.2147/SAR.S138439 [doi]
AB  - This review of contingency management (CM; the behavior-modification method of 
      providing reinforcement in exchange for objective evidence of a desired behavior) 
      for the treatment of substance-use disorders (SUDs) begins by describing the 
      origins of CM and how it has come to be most commonly used during the treatment 
      of SUDs. Our core objective is to review, describe, and discuss three ongoing 
      critical advancements in CM. We review key emerging areas wherein CM will likely 
      have an impact. In total, we qualitatively reviewed 31 studies in a systematic 
      fashion after searching PubMed and Google Scholar. We then describe and highlight 
      CM investigations across three broad themes: adapting CM for underserved 
      populations, CM with experimental technologies, and optimizing CM for 
      personalized interventions. Technological innovations that allow for mobile 
      delivery of reinforcers in exchange for objective evidence of a desired behavior 
      will likely expand the possible applications of CM throughout the SUD-treatment 
      domain and into therapeutically related areas (eg, serious mental illness). When 
      this mobile technology is coupled with new, easy-to-utilize biomarkers, the 
      adaptation for individual goal setting and delivery of CM-based SUD treatment in 
      hard-to-reach places (eg, rural locations) can have a sustained impact on 
      communities most affected by these disorders. In conclusion, there is still much 
      to be done, not only technologically but also in convincing policy makers to 
      adopt this well-established, cost-effective, and evidence-based method of 
      behavior modification.
FAU - McPherson, Sterling M
AU  - McPherson SM
AD  - Department of Medical Education and Clinical Sciences, Elson S Floyd College of 
      Medicine, Washington State University, sterling.mcpherson@wsu.edu.
AD  - Programs of Excellence in Addictions Research, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Analytics and Psychopharmacology Laboratory (APPL), Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Translational Addictions Research Center, Washington State University, 
      sterling.mcpherson@wsu.edu.
FAU - Burduli, Ekaterina
AU  - Burduli E
AD  - Department of Medical Education and Clinical Sciences, Elson S Floyd College of 
      Medicine, Washington State University, sterling.mcpherson@wsu.edu.
AD  - Programs of Excellence in Addictions Research, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Analytics and Psychopharmacology Laboratory (APPL), Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Translational Addictions Research Center, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - College of Nursing, Washington State University.
FAU - Smith, Crystal Lederhos
AU  - Smith CL
AD  - Department of Medical Education and Clinical Sciences, Elson S Floyd College of 
      Medicine, Washington State University, sterling.mcpherson@wsu.edu.
AD  - Programs of Excellence in Addictions Research, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Analytics and Psychopharmacology Laboratory (APPL), Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Translational Addictions Research Center, Washington State University, 
      sterling.mcpherson@wsu.edu.
FAU - Herron, Jalene
AU  - Herron J
AD  - Programs of Excellence in Addictions Research, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Behavioral Health Interventions (BHI), Washington State University, Spokane, WA, 
      USA.
FAU - Oluwoye, Oladunni
AU  - Oluwoye O
AD  - Programs of Excellence in Addictions Research, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Behavioral Health Interventions (BHI), Washington State University, Spokane, WA, 
      USA.
FAU - Hirchak, Katherine
AU  - Hirchak K
AD  - Programs of Excellence in Addictions Research, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Analytics and Psychopharmacology Laboratory (APPL), Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Translational Addictions Research Center, Washington State University, 
      sterling.mcpherson@wsu.edu.
FAU - Orr, Michael F
AU  - Orr MF
AD  - Department of Medical Education and Clinical Sciences, Elson S Floyd College of 
      Medicine, Washington State University, sterling.mcpherson@wsu.edu.
AD  - Programs of Excellence in Addictions Research, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Analytics and Psychopharmacology Laboratory (APPL), Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Translational Addictions Research Center, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - College of Nursing, Washington State University.
FAU - McDonell, Michael G
AU  - McDonell MG
AD  - Department of Medical Education and Clinical Sciences, Elson S Floyd College of 
      Medicine, Washington State University, sterling.mcpherson@wsu.edu.
AD  - Programs of Excellence in Addictions Research, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Analytics and Psychopharmacology Laboratory (APPL), Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Translational Addictions Research Center, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - College of Nursing, Washington State University.
FAU - Roll, John M
AU  - Roll JM
AD  - Department of Medical Education and Clinical Sciences, Elson S Floyd College of 
      Medicine, Washington State University, sterling.mcpherson@wsu.edu.
AD  - Programs of Excellence in Addictions Research, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Analytics and Psychopharmacology Laboratory (APPL), Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - Translational Addictions Research Center, Washington State University, 
      sterling.mcpherson@wsu.edu.
AD  - College of Nursing, Washington State University.
LA  - eng
GR  - P20 MD006871/MD/NIMHD NIH HHS/United States
GR  - R01 AA020248/AA/NIAAA NIH HHS/United States
GR  - R01 AA022070/AA/NIAAA NIH HHS/United States
GR  - R01 DA017407/DA/NIDA NIH HHS/United States
PT  - Journal Article
PT  - Review
DEP - 20180813
PL  - New Zealand
TA  - Subst Abuse Rehabil
JT  - Substance abuse and rehabilitation
JID - 101558476
PMC - PMC6095117
OTO - NOTNLM
OT  - contingency management
OT  - drug- and alcohol-use biomarkers
OT  - novel substance-use treatment technologies
OT  - substance-use disorder treatment
COIS- Disclosure The authors report no conflicts of interest in this work.
EDAT- 2018/08/28 06:00
MHDA- 2018/08/28 06:01
PMCR- 2018/08/13
CRDT- 2018/08/28 06:00
PHST- 2018/08/28 06:00 [entrez]
PHST- 2018/08/28 06:00 [pubmed]
PHST- 2018/08/28 06:01 [medline]
PHST- 2018/08/13 00:00 [pmc-release]
AID - sar-9-043 [pii]
AID - 10.2147/SAR.S138439 [doi]
PST - epublish
SO  - Subst Abuse Rehabil. 2018 Aug 13;9:43-57. doi: 10.2147/SAR.S138439. eCollection 
      2018.